New General Manager for Baxter Healthcare
BAXTER HEALTHCARE LTD has announced Harry Keenan as its new General Manager for the UK. Harry Keenan has spent 24 years with Baxter, where he has held strategic planning and sales and marketing positions of increasing responsibility in Belgium, UK and Ireland. His most recent position is General Manager Greece, Ireland and Portugal, based in Dublin.
“Harry is well-known throughout Baxter from previous roles, and also because of the continuous strong performance of our Irish business,” said Peter Nicklin, President Europe. “It is because of Harry’s experience and track record of success that he has been appointed this position. He is a great asset to our business and we wish him every success in his new role.”
Harry said: “I’m delighted to be appointed as the General Manager for the UK. We have a great team in the UK, a strong business momentum and exciting opportunities ahead.”
Baxter Healthcare Ltd is the primary domestic operating subsidiary of Baxter International Inc. The company specialises in the treatment of complex medical conditions through medical devices, pharmaceuticals and biotechnology.
Toumaz joins Continua Health Alliance
WIRELESS HEALTHCARE COMPANY Toumaz Technology has joined the Continua Health Alliance, an industry group that promotes interoperability across emerging technology-based healthcare systems.
As a full member, Toumaz will gain early access to Continua guidelines and test processes to enable the development of interoperable products and services.
Toumaz recently joined the Alliance’s Technical Working Group and has participated in a number of discussions centred around its Sensium™ system, a new ultra-low power wireless infrastructure system for health and lifestyle monitoring applications.
“Toumaz’s vision of proactive, cost-effective personal connected healthcare is shared by the members of the Continua Alliance,” said Keith Errey, Toumaz Technology’s co-founder and COO. “As the provider of a key enabling technology in the emerging personal telehealth ecosystem, it is obviously vital for Toumaz to take a role in this important organisation and support it in its aim – to deliver highly integrated systems that work together to improve the quality of people’s lives.”
The Continua Health Alliance is a collaborative open industry alliance made up of technology, medical device and healthcare industry leaders. Members include Cisco, GE, IBM, Intel, Kaiser Permanente, Medtronic, Motorola, Oracle, Panasonic, Philips, Partners Healthcare, Samsung, Sharp and Welch Allyn.
IRONMAN and iron woman
DICK AND CLARE DONOVAN, the Directors of Helix Recruitment, are aiming to raise £1000 for WaterAid – the hard way. At 7am on Sunday July 8th, they will join more than 2000 competitors at Klagenfurt for the IRONMAN Austria triathlon (see www.ironmanaustria.com). IRONMAN triathlons are gruelling long-distance events comprising a 3.8km swim, a 180km bike ride and a full marathon (42km). Training for this achievement involves long weekly runs and shorter daily ones, five-hour bicycle rides, and swim training in open (unheated) water.
Having completed the Switzerland IRONMAN event in 2005, Dick is aiming for an even better time (under 13 hours) this year. Clare, attempting the event for the first time, is aiming to fulfil the IRONMAN mantra that just finishing is a victory! You can monitor their progress via www.ironmanlive.com. Not content with one triathlon in 2007, they have booked another assault on the event at IRONMAN Florida in November – sharks willing (the swim is in the Gulf of Mexico).
You can show your support by sponsoring them on behalf of WaterAid at www.justgiving.com/dickandclare. WaterAid is dedicated to the provision of safe domestic water, sanitation and hygiene education worldwide. Helix Recruitment offers a specialist recruitment service to the laboratory and healthcare products marketplace.
Smith & Nephew appoints new Chief Executive
SIR CHRISTOPHER O’DONNELL will retire as chief executive of medical devices company Smith & Nephew at the end of June. He will be replaced by David Illingworth, who has been Chief Operating Officer since February 2006 and headed up Smith & Nephew’s orthopaedics division prior to that. Sir Christopher joined Smith & Nephew in 1988 and has been Chief Executive since 1997. Since 2003 he has jointly chaired the UK government/industry Healthcare Industries Task Force.
David Illingworth (53) has 28 years’ experience in the medical technology industry, including 15 years with GE Medical. He has led companies in the areas of diagnostic imaging, respiratory devices and urological products, as well as heading up a technology incubator company.
John Buchanan, Smith & Nephew’s Chairman, thanked Sir Christopher: “During his ten years as Chief Executive, Chris O’Donnell has transformed Smith & Nephew into a focused global leader in medical devices and created substantial shareholder value.”
He added: “We are delighted to announce the promotion of David Illingworth to Chief Executive. His extensive medical technology experience with GE Medical and other leading medtech companies, coupled with the strong business performance he has demonstrated as President of our Orthopaedics businesses, and latterly as Chief Operating Officer, show he has the leadership qualities needed to continue the development of Smith & Nephew as an outstanding medical device company.”
Smith & Nephew is the biggest medical device manufacturer in Europe. Its product range includes knee and hip replacements and dressings for acute wounds.
Owen Mumford opens new manufacturing facility
MEDICAL DEVICE COMPANY OWEN MUMFORD has opened an extended manufacturing facility in Chipping Norton. The opening was presented by the Rt. Hon. David Cameron, MP, Leader of the Conservative Party. Forty million drug delivery devices will be produced at the new facility, and over 100 new jobs will be created.
Owen Mumford is a family-owned company with over 50 years’ experience in the design, development and manufacture of medical devices used by healthcare professionals and patients worldwide. Its Cotswold division in Chipping Norton manufactures automatic injection devices.
The recent growth in the management of long-term conditions by patients who self-inject medication, using bespoke autoinjector and pen technology, has led to increasing demand for the medical devices produced by Owen Mumford, whose branded products are purchased by hospitals, clinics and pharmacies.
Adam Mumford, Managing Director of Owen Mumford, commented: “As a successful and growing business, this expanded site will enable us to produce more new products and greater volumes, to meet the increased demand from patients, healthcare professionals and pharmaceutical and diagnostic partners.”